<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Commercialdiligence - Latest News</title>
<link href="https://news.prfree.org/rss/commercialdiligence/latest.xml"></link>
<updated>2026-07-21T18:03:32+00:00</updated>
<id>urn:uuid:d57120ae-c889-c35c-3e96-8bd1f3a0923a</id>
<entry>
<title>Commercial Due Diligence specialist, BiopharmaVantage advises on a transdermal drug delivery deal</title>
<link href="https://news.prfree.org/@commercialdiligence/commercial-due-diligence-specialist-biopharmavantage-advises-on-a-transdermal-drug-delivery-deal-eqmj8j8p6mr6"></link>
<id>urn:uuid:84a77932-2730-0e6f-908e-a9e4c51b0d54</id>
<summary type="html"><![CDATA[Healthcare Commercial Due Diligence expert, BiopharmaVantage advises on investment in a novel transdermal drug delivery business]]></summary>
<updated>2018-01-30T13:15:09+00:00</updated>
</entry>
<entry>
<title>Pharmaceutical CI expert, BiopharmaVantage discusses leveraging sales force competitive intelligence</title>
<link href="https://news.prfree.org/@commercialdiligence/pharmaceutical-ci-expert-biopharmavantage-discusses-leveraging-sales-force-competitive-intelligence-b7kxa3wr6mry"></link>
<id>urn:uuid:ababf388-c9fc-3d6b-b131-eb3da5b66c0d</id>
<summary type="html"><![CDATA[Benchmarking refers to the comparison of the metrics, processes and practices of a particular business to the others in the industry.]]></summary>
<updated>2017-11-12T18:43:20+00:00</updated>
</entry>
<entry>
<title>BiopharmaVantage discusses DCF valuation in the healthcare and life sciences sector</title>
<link href="https://news.prfree.org/@commercialdiligence/biopharmavantage-discusses-dcf-valuation-in-the-healthcare-and-life-sciences-sector-63mb76aaxkb7"></link>
<id>urn:uuid:13b26ed1-bf69-4261-e05a-139715ae74cc</id>
<summary type="html"><![CDATA[Valuation often happens to be the most widely discussed topic in several conferences and forms many research theses. Currently, DCF and comparables based methods are mostly employed valuation methods.]]></summary>
<updated>2017-10-20T11:21:04+00:00</updated>
</entry>
<entry>
<title>BiopharmaVantage discusses the quality of competitive intelligence in the pharmaceutical industry</title>
<link href="https://news.prfree.org/@commercialdiligence/biopharmavantage-discusses-the-quality-of-competitive-intelligence-in-the-pharmaceutical-industry-ypm4rwwaym85"></link>
<id>urn:uuid:7faddc64-96d3-dff5-ffe4-77d6021c568d</id>
<summary type="html"><![CDATA[The insights gathered from competitive intelligence (CI) engagements are intelligence not data, thus CI based insights are not amenable to most quantitative methods.]]></summary>
<updated>2017-09-14T14:20:37+00:00</updated>
</entry>
<entry>
<title>BiopharmaVantage the specialist Healthcare and Life Sciences Commercial Due Diligence firm</title>
<link href="https://news.prfree.org/@commercialdiligence/biopharmavantage-the-specialist-healthcare-and-life-sciences-commercial-due-diligence-firm-eqm377yynmdy"></link>
<id>urn:uuid:a90e90a5-ccd0-3332-5145-e9f58e56689e</id>
<summary type="html"><![CDATA[BiopharmaVantage, the specialist Healthcare and Life Sciences Commercial Due Diligence firm, advises on the Investment in an Immunotherapy Business]]></summary>
<updated>2017-09-08T14:39:15+00:00</updated>
</entry>
<entry>
<title>Biosimilars Competitive Intelligence in the Pharmaceutical and Biotechnology Industry</title>
<link href="https://news.prfree.org/@commercialdiligence/biosimilars-competitive-intelligence-in-the-pharmaceutical-and-biotechnology-industry-3bmnya53ak6p"></link>
<id>urn:uuid:067d2e10-3b23-d136-fbe4-fdae52c9021b</id>
<summary type="html"><![CDATA[Biosimilars Competitive Intelligence in the Pharmaceutical and Biotechnology Industry]]></summary>
<updated>2017-08-21T18:33:09+00:00</updated>
</entry>
<entry>
<title>Key Success Factors in the Commercial Due Diligence of Investment in the Healthcare</title>
<link href="https://news.prfree.org/@commercialdiligence/key-success-factors-in-the-commercial-due-diligence-of-investment-in-the-healthcare-ypm44ne3em85"></link>
<id>urn:uuid:f247e672-d021-0a93-a362-794917605548</id>
<summary type="html"><![CDATA[Due diligence is the process by which buyers conduct investigation and evaluation of potential acquisitions and investments.]]></summary>
<updated>2017-05-25T11:41:29+00:00</updated>
</entry>
</feed>